2-piperidone has been researched along with Coronary Artery Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chirananthavat, T; Claimon, T; Sanpatchayapong, A; Satirapoj, B; Suraamornkul, S; Trakarnvanich, T | 1 |
1 trial(s) available for 2-piperidone and Coronary Artery Disease
| Article | Year |
|---|---|
Effect of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Biomarkers of Kidney Injury and Vascular Calcification in Diabetic Kidney Disease: A Randomized Controlled Trial.
Topics: Aged; Alkaline Phosphatase; Ankle Brachial Index; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Fatty Acid-Binding Proteins; Female; Glomerular Filtration Rate; Hepatitis A Virus Cellular Receptor 1; Humans; Lipocalin-2; Male; Middle Aged; Osteopontin; Piperidones; Pulse Wave Analysis; Pyrimidines; Reactive Oxygen Species; Vascular Calcification | 2021 |